Company Directory / Research Services
PrivateFor profitResearch ServicesCambridge, MA, United States
Umedeor
uMed enables healthcare providers to run patient research more efficiently through automating the clinical studies process
- Founded
- 2017 9 years ago
- Staff
- 51-100 77 on LinkedIn
- Followers
- 7k on LinkedIn
- Funding
- $18M as listed, USD
uMed combines RWE with the power of patient generated data to address the evidence gaps in life science research. By leveraging uMed’s ACCESS Research Platform which is embedded across a global network of healthcare institutions, researchers can rapidly access and engage with patients to generate insights derived from the decentralised collection of electronic health records, clinical outcomes, patient-reported data and biosamples.
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed. 77 people list it on LinkedIn.
Age
9 years old.
Reach
Website ranked #5,869,257 in the world for traffic, about 1k visits a month. 7,282 followers on LinkedIn.
What it does
Health CareInformation TechnologyLife ScienceMedicalmHealthSoftware
Funding, as listed
$18M raised in total
- Rounds5
- LatestSeries a, Jul 2023
- Latest amountUSD 12,450,357
- Investors7, 3 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Umedeor, field by field. Contact details are held but never shown.
The company
- Name
- Umedeor
- Type
- For profit
- Status
- Private
- Founded
- 2017
- Founders
- Matt Wilson
- Industry
- Research Services
- Categories
- Health Care, Information Technology, Life Science, Medical, mHealth, Software
Where
- City
- Cambridge
- Region
- MA
- Country
- United States
- Markets
- Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 51-100
- People on LinkedIn
- 77
- LinkedIn followers
- 7,282
- Web traffic rank
- #5,869,257
- Monthly web visits
- 1,197
Funding, as listed
- Total
- $18,363,642 USD
- Rounds
- 5
- Latest round
- Series a
- Latest round date
- Jul 2023
- Latest amount
- 12,450,357 USD
- Investors
- 7
- Lead investors
- 3
- Listing status
- private
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Growth, as the source summarises it
Umedeor may be growing as it has recently received an investment of £0.6 million, which suggests an influx of capital that could be used for expansion, research and development, or other growth-related activities. This financial support from investors indicates a level of confidence in Umedeor's potential and business model. Additionally, the context of the investment implies that the company is part of a sector that is recovering, which could further facilitate its growth.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Research Services in United States.
Nurses InkPelham · 1 followers
Science 37Morrisville · 251-500 people · 27k followers
Cyteir TherapeuticsLexington · 11-50 people · 5k followersNNorthwestern University Clinical &Translational Sciences Institute (NUCATS)Chicago · 11-50 people · 561 followers
Strong StarSan Antonio · 51-100 people · 989 followers
20/20 Gene SystemsRockville · 11-50 people · 895 followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.